 |
The Journal of Neuroscience, September 28, 2005, 25(39):8954-8966; doi:10.1523/JNEUROSCI.2899-05.2005
Previous Article | Next Article 
Neurobiology of Disease
Differential Roles of Nuclear and Cytoplasmic Cyclin-Dependent Kinase 5 in Apoptotic and Excitotoxic Neuronal Death
Michael J. O'Hare,1
Neena Kushwaha,1
Yi Zhang,1
Hossein Aleyasin,1
Steven M. Callaghan,1
Ruth S. Slack,1
Paul R. Albert,1
Inez Vincent,2 and
David S. Park1
1Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa Health Research Institute, Neuroscience Group, Ottawa, Ontario, Canada K1H 8M5, and 2The Nathan Shock Center of Excellence in the Basic Biology of Aging and Department of Pathology, University of Washington, Seattle, Washington 98195
Cyclin-dependent kinase 5 (cdk5) is a member of the cyclin-dependent kinase family whose activity is localized mainly to postmitotic neurons attributable to the selective expression of its activating partners p35 and p39. Deregulation of cdk5, as a result of calpain cleavage of p35 to a smaller p25 form, has been suggested to be a central component of neuronal death underlying numerous neurodegenerative diseases. However, the relevance of cdk5 in apoptotic death that relies on the mitochondrial pathway is unknown. Furthermore, evidence that cdk5 can also promote neuronal survival has necessitated a more complex understanding of cdk5 in the control of neuronal fate. Here we explore each of these issues using apoptotic and excitotoxic death models. We find that apoptotic death induced by the DNA-damaging agent camptothecin is associated with early transcription-mediated loss of p35 and with late production of p25 that is dependent on Bax, Apaf1, and caspases. In contrast, during excitotoxic death induced by glutamate, neurons rapidly produce p25 independent of the mitochondrial pathway. Analysis of the localization of p35 and p25 revealed that p35 is mainly cytoplasmic, whereas p25 accumulates selectively in the nucleus. By targeting a dominant-negative cdk5 to either the cytoplasm or nucleus, we show that cdk5 has a death-promoting activity within the nucleus and that this activity is required in excitotoxic death but not apoptotic death. Moreover, we also find that cdk5 contributes to pro-survival signaling selectively within the cytoplasm, and manipulation of this signal can modify death induced by both excitotoxicity and DNA damage.
Key words: apoptosis; cell cycle; p35; cdk5; excitotoxicity; DNA damage
Received Feb 23, 2005;
revised August 16, 2005;
accepted August 17, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
K.-H. Sun, H.-g. Lee, M. A. Smith, and K. Shah
Direct and Indirect Roles of Cyclin-dependent Kinase 5 as an Upstream Regulator in the c-Jun NH2-Terminal Kinase Cascade: Relevance to Neurotoxic Insults in Alzheimer's Disease
Mol. Biol. Cell,
November 1, 2009;
20(21):
4611 - 4619.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rashidian, M. W. Rousseaux, K. Venderova, D. Qu, S. M. Callaghan, M. Phillips, R. J. Bland, M. J. During, Z. Mao, R. S. Slack, et al.
Essential Role of Cytoplasmic cdk5 and Prx2 in Multiple Ischemic Injury Models, In Vivo
J. Neurosci.,
October 7, 2009;
29(40):
12497 - 12505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Endo, T. Saito, A. Asada, H. Kawahara, T. Ohshima, and S.-i. Hisanaga
Commitment of 1-Methyl-4-phenylpyrinidinium Ion-induced Neuronal Cell Death by Proteasome-mediated Degradation of p35 Cyclin-dependent Kinase 5 Activator
J. Biol. Chem.,
September 18, 2009;
284(38):
26029 - 26039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ma, Y. Zhao, Y.-D. Kwak, Z. Yang, R. Thompson, Z. Luo, H. Xu, and F.-F. Liao
Statin's Excitoprotection Is Mediated by sAPP and the Subsequent Attenuation of Calpain-Induced Truncation Events, Likely via Rho-ROCK Signaling
J. Neurosci.,
September 9, 2009;
29(36):
11226 - 11236.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Lagace, D. R. Benavides, J. W. Kansy, M. Mapelli, P. Greengard, J. A. Bibb, and A. J. Eisch
Cdk5 is essential for adult hippocampal neurogenesis
PNAS,
November 25, 2008;
105(47):
18567 - 18571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Lee, M.-W. Jeong, W. Kim, Y. H. Choi, and K.-T. Kim
Cooperative Roles of c-Abl and Cdk5 in Regulation of p53 in Response to Oxidative Stress
J. Biol. Chem.,
July 11, 2008;
283(28):
19826 - 19835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Sun, Y. de Pablo, F. Vincent, E. O. Johnson, A. K. Chavers, and K. Shah
Novel Genetic Tools Reveal Cdk5's Major Role in Golgi Fragmentation in Alzheimer's Disease
Mol. Biol. Cell,
July 1, 2008;
19(7):
3052 - 3069.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang, S. A. Cicero, L. Wang, R. R. Romito-DiGiacomo, Y. Yang, and K. Herrup
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons
PNAS,
June 24, 2008;
105(25):
8772 - 8777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. He, Z. Hou, and R. Z. Qi
Calmodulin Binding and Cdk5 Phosphorylation of p35 Regulate Its Effect on Microtubules
J. Biol. Chem.,
May 9, 2008;
283(19):
13252 - 13260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. H. Cheung, K. Gong, and N. Y. Ip
Cyclin-Dependent Kinase 5 Supports Neuronal Survival through Phosphorylation of Bcl-2
J. Neurosci.,
May 7, 2008;
28(19):
4872 - 4877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Muyllaert, D. Terwel, A. Kremer, K. Sennvik, P. Borghgraef, H. Devijver, I. Dewachter, and F. Van Leuven
Neurodegeneration and Neuroinflammation in cdk5/p25-Inducible Mice: A Model for Hippocampal Sclerosis and Neocortical Degeneration
Am. J. Pathol.,
February 1, 2008;
172(2):
470 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Anne, F. Saudou, and S. Humbert
Phosphorylation of Huntingtin by Cyclin-Dependent Kinase 5 Is Induced by DNA Damage and Regulates Wild-Type and Mutant Huntingtin Toxicity in Neurons
J. Neurosci.,
July 4, 2007;
27(27):
7318 - 7328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-H. Lee, H.-S. Kim, S.-J. Lee, and K.-T. Kim
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death
J. Cell Sci.,
July 1, 2007;
120(13):
2259 - 2271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lin, M.-C. Chen, C.-Y. Chiu, Y.-M. Song, and S.-Y. Lin
Cdk5 Regulates STAT3 Activation and Cell Proliferation in Medullary Thyroid Carcinoma Cells
J. Biol. Chem.,
February 2, 2007;
282(5):
2776 - 2784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kamei, T. Saito, M. Ozawa, Y. Fujita, A. Asada, J. A. Bibb, T. C. Saido, H. Sorimachi, and S.-i. Hisanaga
Suppression of Calpain-dependent Cleavage of the CDK5 Activator p35 to p25 by Site-specific Phosphorylation
J. Biol. Chem.,
January 19, 2007;
282(3):
1687 - 1694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Smith, M. P. Mount, R. Shree, S. Callaghan, R. S. Slack, H. Anisman, I. Vincent, X. Wang, Z. Mao, and D. S. Park
Calpain-Regulated p35/cdk5 Plays a Central Role in Dopaminergic Neuron Death through Modulation of the Transcription Factor Myocyte Enhancer Factor 2
J. Neurosci.,
January 11, 2006;
26(2):
440 - 447.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|